Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898432-23-000124
Filing Date
2023-02-23
Accepted
2023-02-23 16:30:35
Documents
1
Period of Report
2023-02-21

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5230
  Complete submission text file 0000898432-23-000124.txt   6770
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Issuer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 (425) 635-7700
Bellevue Global Life Science Investors LLC (Reporting) CIK: 0001953768 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41390 | Film No.: 23660147